跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 49,214 条关于
“Ladenburg Thalmann & Co. Inc.”
全部
49,214
临床试验
13,768
药物
2,542
机构
7,629
资讯
25,275
去年
Calidi Biotherapeutics Announces $7.5 Million Public Offering to Advance Clinical Trials
3个月前
Ladenburg Thalmann Expands Biotechnology Equity Research Team with Two Senior Analysts
去年
Cellectar Biosciences Raises $2.5 Million Through Warrant Exercise to Advance Cancer Drug Development
11个月前
Akari Therapeutics Secures $5 Million Financing to Advance Novel ADC Platform with Spliceosome Modulator Payload
11个月前
Cellectar Biosciences Raises $5.8 Million Through Warrant Exercise to Advance Cancer Drug Pipeline
3个月前
Copley Acquisition and Ignite Proteomics Strike $150M SPAC Deal to Bring Precision Oncology Proteomics Platform to Public Markets
去年
Jaguar Health's Napo Therapeutics Advances Crofelemer for Rare Intestinal Diseases in Europe
去年
KEYNOTE-057 Trial Explores Vibostolimab and Favezelimab Combinations with Pembrolizumab in BCG-Unresponsive NMIBC
21天前
Heidelberg Pharma and Huadong Medicine Expand Partnership to Co-Develop Next-Generation Antibody Drug Conjugates
去年
FDA Approves Verquvo (vericiguat) for Chronic Heart Failure with Reduced Ejection Fraction
第 1 页，共 2528 页
上一页
下一页
